Phio Pharmaceuticals (PHIO) Return on Capital Employed Growth (5y) (2017 - 2025)
Phio Pharmaceuticals (PHIO) Return on Capital Employed Growth (5y) (2017 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Phio Pharmaceuticals | 13.77 Mn | 13.77 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | -937.00 |
| Mar 31, 2025 | 1,484.00 |
| Dec 31, 2024 | -2,915.00 |
| Sep 30, 2024 | -7,440.00 |
| Jun 30, 2024 | -15,246.00 |
| Mar 31, 2024 | -9,365.00 |
| Dec 31, 2023 | -4,431.00 |
| Sep 30, 2023 | 13,072.00 |
| Jun 30, 2023 | 33,305.00 |
| Mar 31, 2023 | 72,072.00 |
| Dec 31, 2022 | 108,304.00 |
| Sep 30, 2022 | 40,238.00 |
| Jun 30, 2022 | 38,681.00 |
| Mar 31, 2022 | 17,941.00 |
| Dec 31, 2021 | 7,892.00 |
| Sep 30, 2021 | 19,589.00 |
| Jun 30, 2021 | 12,868.00 |
| Mar 31, 2021 | 6,835.00 |
| Dec 31, 2020 | 4,654.00 |
| Sep 30, 2020 | 2,863.00 |